Tag: Genprex

Genprex begins dosing of phase 1/2 trial of REQORSA, Tagrisso combo

pallavi123- March 6, 2022

Genprex has dosed the first patient in the Acclaim-1 phase 1/2 clinical trial of REQORSA immunogene therapy candidate in combination with Tagrisso (osimertinib) in a ... Read More

Lung cancer drug Oncoprex phase II trial : Genprex reports positive interim data results

pharmanewsdaily- January 7, 2017

Texas based bio-pharma Genprex has announced positive interim data from an ongoing phase II clinical trial of its lung cancer drug candidate Oncoprex. Titled as ... Read More